Experienced in Abdominal Aortic Aneurysm (AAA)

Sebastien Gaertner

Chu
Strasbourg, FR 
Experienced in Abdominal Aortic Aneurysm (AAA)
Chu
Strasbourg, FR 
OverviewLocationsClinical Research

Overview

Sebastien Gaertner practices in Strasbourg, France. Mr. Gaertner is rated as an Experienced expert by MediFind in the treatment of Abdominal Aortic Aneurysm (AAA). His top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Embolism, Peripheral Artery Disease, and Atherosclerosis.

His clinical research consists of co-authoring 45 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Abdominal Aortic Aneurysm (AAA).

Gender
Male

Locations

CHU
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Enrollment Status: Terminated
Publish Date: October 19, 2022
Intervention Type: Drug
Study Drugs: Apixaban, Rivaroxaban, Heparin, VKA
Study Phase: Phase 3
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Enrollment Status: Completed
Publish Date: August 25, 2022
Intervention Type: Other
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
Detect, Monitor and Prevent Vascular Abnormalities Associated With Turner Syndrome
Detect, Monitor and Prevent Vascular Abnormalities Associated With Turner Syndrome
Enrollment Status: Unknown
Publish Date: June 30, 2022
Intervention Type: Procedure
View 3 Less Clinical Trials

45 Total Publications

Postmortem data collection protocol for cardiac implantable electronic devices by the forensic pathologists: how to avoid conflicts of interest and minimize data loss?
Postmortem data collection protocol for cardiac implantable electronic devices by the forensic pathologists: how to avoid conflicts of interest and minimize data loss?
Journal: International journal of legal medicine
Published: March 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gaertner's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile